MLchartDataset catalogue

Green tea lozenge

Term · Oncology and biomedicine · MLC-T-ONC-014036

A lozenge formulation of green tea, derived from the dried leaves of Camellia sinensis, with potential antioxidant and chemopreventive activities. Green tea lozenge contains polyphenols that may be responsible for its chemopreventive effect. The polyphenol fraction contains mainly epigallocatechin-3-gallate (EGCG) and other catechins, such as epicatechin (EC), gallocatechin gallate (GCG), epigallocatechin (EGC), and epicatechin gallate (ECG). Green tea polyphenols act as antioxidants and free radical scavengers, protecting cells from the damaging effects of reactive oxygen species (ROS).

Table 1. Record
IdentifierMLC-T-ONC-014036
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014036",
  "term": "Green tea lozenge",
  "field": "Oncology and biomedicine",
  "definition": "A lozenge formulation of green tea, derived from the dried leaves of Camellia sinensis, with potential antioxidant and chemopreventive activities. Green tea lozenge contains polyphenols that may be responsible for its chemopreventive effect. The polyphenol fraction contains mainly epigallocatechin-3-gallate (EGCG) and other catechins, such as epicatechin (EC), gallocatechin gallate (GCG), epigallocatechin (EGC), and epicatechin gallate (ECG). Green tea polyphenols act as antioxidants and free radical scavengers, protecting cells from the damaging effects of reactive oxygen species (ROS).",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/green-tea-lozenge/"
}

Record 8,196 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.